Detalles de la búsqueda
1.
Low incidence of tumor lysis syndrome in elderly patients with chronic lymphocytic leukemia treated with venetoclax under real-world conditions: results from the prospective observational VeRVe study.
Ann Hematol
; 103(6): 2013-2020, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38421404
2.
Effectiveness, safety and quality of life of trifluridine/tipiracil in pretreated patients with metastatic colorectal cancer: Real-world data from the noninterventional TACTIC study in Germany.
Int J Cancer
; 153(6): 1227-1240, 2023 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37260368
3.
FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) Study.
J Clin Oncol
; 41(25): 4143-4153, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37352476
4.
First-line fluoropyrimidine plus bevacizumab followed by irinotecan-escalation versus initial fluoropyrimidine, irinotecan and bevacizumab in patients with metastatic colorectal cancer - Final survival and per-protocol analysis of the randomised XELAVIRI trial (AIO KRK 0110).
Eur J Cancer
; 173: 194-203, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35940054
5.
Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE.
NPJ Breast Cancer
; 8(1): 106, 2022 Sep 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36117201
6.
Consensus molecular subtypes in metastatic colorectal cancer treated with sequential versus combined fluoropyrimidine, bevacizumab and irinotecan (XELAVIRI trial).
Eur J Cancer
; 157: 71-80, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34507244
7.
Impact of age on efficacy and early mortality of initial sequential treatment versus upfront combination chemotherapy in patients with metastatic colorectal cancer: a subgroup analysis of a phase III trial (AIO KRK0110, XELAVIRI study).
Eur J Cancer
; 137: 81-92, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32750502
8.
Sequential Versus Combination Therapy of Metastatic Colorectal Cancer Using Fluoropyrimidines, Irinotecan, and Bevacizumab: A Randomized, Controlled Study-XELAVIRI (AIO KRK0110).
J Clin Oncol
; 37(1): 22-32, 2019 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30388045
9.
Allogeneic dendritic cells fused with tumor cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma.
Hum Gene Ther
; 14(5): 483-94, 2003 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-12691613
10.
Second-line oxaliplatin, folinic acid, and fluorouracil versus folinic acid and fluorouracil alone for gemcitabine-refractory pancreatic cancer: outcomes from the CONKO-003 trial.
J Clin Oncol
; 32(23): 2423-9, 2014 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24982456
11.
Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: a phase III-study from the German CONKO-study group.
Eur J Cancer
; 47(11): 1676-81, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21565490
Resultados
1 -
11
de 11
1
Próxima >
>>